previously

Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results

CAMBRIDGE, Mass., Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX), a company developing novel…

2 weeks ago

Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today announced that it has heard from more…

2 weeks ago

CQ Medical Appoints Michael Galbus as Chief Executive Officer, Mike Sutter as Chairman of the Board of Directors

AVONDALE, Pa., Nov. 3, 2025 /PRNewswire/ -- CQ Medical is pleased to announce the appointment of Michael Galbus as Chief Executive…

3 weeks ago

Manulife Completes Acquisition of Comvest Credit Partners

TSX/NYSE/PSE: MFC SEHK: 945   TORONTO, Nov. 3, 2025 /PRNewswire/ -- Manulife Financial Corporation (TSX: MFC), through its more than US$900 billion Global…

3 weeks ago

Law Offices of Howard G. Smith Encourages James Hardie Industries plc (JHX) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of…

4 weeks ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

1 month ago

Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program

REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…

1 month ago

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Headlines: Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1 Enables accurate analysis of protein complexes,…

1 month ago

Automobili Lamborghini strengthens its Board of Management

New appointments to support the future strategy of the Sant’Agata Bolognese companySant’Agata Bolognese, 9th October 2025 – Automobili Lamborghini announces…

2 months ago

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ:…

2 months ago